WST Earnings

Quarterly EPS
$1.87
Q3 2024
$1.79
Q4 2024
$1.24
Q1 2025
$1.82
Q2 2025
$1.94
Q3 2025
$1.83
Q4 2025
$1.93
Q1 2026
$2.17
Q2 2026
Latest Revenue872.3M
Latest Net Income154.0M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$2.17872.3M154.0M+13.8%+19.2%
Q1 2026$1.93844.9M138.8M+21.0%+55.6%
Q4 2025$1.83805.0M132.1M+7.5%+2.2%
Q3 2025$1.94804.6M140.0M+7.7%+3.7%
Q2 2025$1.82766.5M131.8M+9.2%+19.7%
Q1 2025$1.24698.0M89.8M+0.4%-21.0%
Q4 2024$1.79748.8M130.1M+2.3%-3.2%
Q3 2024$1.87746.9M136.0M-0.1%-13.8%
Q2 2024$1.52702.1M111.3M
Q1 2024$1.57695.4M115.3M
Q4 2023$1.85732.0M137.0M
Q3 2023$2.17747.4M161.3M
West Pharmaceutical Services (WST) — Earnings